Article contents
Tianeptine: clinical properties
Published online by Cambridge University Press: 16 April 2020
Summary
Tianeptine has been shown to be an effective antidepressant versus reference drugs and to be better tolerated than amitriptyline, without the latter's anticholinergic side-effects. Its good acceptability has been confirmed in long-term use (1 year) in large patient groups. In an open pilot trial in endogenous melancholia, tianeptine showed the same activity as would be expected of a conventional antidepressant. This is being verified in a double-blind trial versus maprotiline. In a separate open study, it has demonstrated a potential to prevent relapse and recurrence in depressed patients treated for 1 year. These results are currently being tested versus placebo.
- Type
- Research Article
- Information
- European Psychiatry , Volume 8 , Issue S2: Neuroendocrinological aspects of depression 28 June 1992, Nice, France , 1993 , pp. 103s - 109s
- Copyright
- Copyright © Elsevier, Paris 1993
References
- 4
- Cited by
Comments
No Comments have been published for this article.